References
Chatterjee, S, Prayson, R, and Farver, C. Antisynthetase syndrome: Not
just an inflammatory myopathy. Cleveland Clinic Journal of
Medicine. October 2013; 80(10): 655-666.
Giannini, M., Notarnicola, A., Dastmalchi, M. et al. Heterogeneous
clinical spectrum of interstitial lung disease in patients with anti-EJ
anti-synthetase syndrome: a case series. Clin Rheumatol. 2016;
35, 2363–2367. DOI: https://doi.org/10.1007/s10067-016-3258-1;
Mahler, M, Miller, FW, and Fritzler, MJ. Idiopathic inflammatory
myopathies and the anti-synthetase syndrome: A comprehensive review.Autoimmunity Revews. 2014; 13: 367-371.
Doyle, TJ, Dhillon, N, and Madan, R, et al. Rituximab in the Treatment
of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A
Multicenter Retrospective Case Review. The Journal of
Rheumatology. Jun 2018; 45 (6) 841-850; DOI: 10.3899/jrheum.170541
Cavagna, L., Nuño, L., Scirè, C.A. et al. Serum Jo-1 Autoantibody and
Isolated Arthritis in the Antisynthetase Syndrome: Review of the
Literature and Report of the Experience of AENEAS Collaborative Group.Clinic Rev Allerg Immunol . 2017; 52, 71–80. DOI:
https://doi.org/10.1007/s12016-016-8528-9
Theodorou DJ, Theodorou SJ, Kakitsubata Y. Skeletal muscle disease:
patterns of MRI appearances. Br J Radiol . 2012;
85(1020):e1298-e1308. DOI:10.1259/bjr/14063641.